Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China

Inclusion Criteria: * The body mass index (BMI) is 19.0 to 26.0 kg/m2 (including the cut-off), and the subject must weigh no less than 50kg. * Before the test, fully understand the test content, process and possible adverse reactions, and voluntarily sign the informed consent. Exclusion Criteria: * People with an allergic disposition (multiple drug and food allergies) or who, as determined by the investigator, are likely to be allergic to the investigational drug product or any component of the investigational drug product. * Subjects with a pre-existing or present history of metabolic, liver, kidney, hematological, pulmonary, cardiovascular, gastrointestinal, urinary, endocrine, neurological, or psychiatric disease with clinical manifestations that the investigator deems unsuitable for participation in this study. * Hemorrhoids or perianal disease with regular/ongoing blood in the stool, irritable bowel syndrome, inflammatory bowel disease. * Screening for novel coronavirus infection: Those who are positive for novel coronavirus nucleic acid. * Physical examination, vital signs, routine laboratory examination , thyroid function, chest CT, abdominal B-ultrasound and other tests were abnormal with clinical significance. * Estimated glomerular filtration rate \<90 mL/min/1.73 m2 (see Appendix 1 for eGFR formula). * Resting corrected QT interval (QTcF) ≥450ms, QRS≥120ms obtained by 12-lead electrocardiogram (ECG). * Any conditions that may affect drug absorption, such as gast…